Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?

MLA

Hendriks, L., et al. Does Radiomics Have Added Value in Predicting the Development of Brain Metastases in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer (NSCLC)? Apr. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........2205b07f7d6644650bfc21d9a730adde&authtype=sso&custid=ns315887.

APA

Hendriks, L., Keek, S. A., Chatterjee, A., Belderbos, J., Bootsma, G., van den Borne, B., Dingemans, A.-M. C., Gietema, H., Groen, H. J. M., Herder, G., Pitz, C., Praag, J., De Ruysscher, D., Schoenmaekers, J., Smit, H. J. M., Stigt, J., Westenend, M., Zeng, H., Woodruff, H., & Lambin, P. (2022). Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?

Chicago

Hendriks, L., S. A. Keek, A. Chatterjee, J. Belderbos, G. Bootsma, B. van den Borne, A-M. C. Dingemans, et al. 2022. “Does Radiomics Have Added Value in Predicting the Development of Brain Metastases in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer (NSCLC)?,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........2205b07f7d6644650bfc21d9a730adde&authtype=sso&custid=ns315887.